Healthcare ❯ Pharmaceuticals ❯ Clinical Trials ❯ Pulmonary Arterial Hypertension

Drug Development

Gossamer Bio Faces Securities Class Action After PROSERA Failure, 80% Stock Plunge

Plaintiffs question PROSERA disclosures citing Latin America placebo effects plus trial design risks.